DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users. (DIUQoL)

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: Levonorgestrel IUD or Copper IUD

Study type: Observational

Funder types: Industry

Identifiers

NCT01731132

MA1213ES (Other Identifier)

16341

BAY-DIU-2011-01 (Other Identifier)

Details and patient eligibility

About

Knowledge about the impact on quality of life of women initiating IUD in the Spanish population at baseline and after 12 months of use.

Enrollment: 207 patients

Sex: Female

Ages: 18 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-49 years old female.
• Women who is visited by a gynecology or primary care physician and starts contraception with an IUD/IUS.
• Women that has not used hormonal contraception in any form in the last 3 months.
• Women who have no problems listening, reading or writing.
• Women who gives their written consent to participate in the study.

Exclusion criteria

• Women who have contraindications to use IUDs.
• Women with previous experience with IUDs.
• Women who initiates the use of IUDs for other purposes other than contraception.
• Woman who is participating in a clinical trial at the time of initiating the study.

Trial design

207 participants in 1 patient group

Group 1

Treatment:

Drug: Levonorgestrel IUD or Copper IUD